Silver Nanoparticles in Multidrug Resistant Bacteria
Sponsor
Assiut University (Other)
Overall Status
Completed
CT.gov ID
NCT04431440
Collaborator
(none)
150
1
4.4
34.1
Study Details
Study Description
Brief Summary
Recently, silver nanoparticles (AgNPs) have been widely used in various applications as antimicrobial agents, anticancer, diagnostics, biomarkers, cell labels, and drug delivery systems for the treatment of various diseases. The present study investigated the bactericidal effect of AgNPs against Methecillin Resistant Staph. aureus (MRSA) and Vancomycin resistant Staph aureus (VRSA)
| Condition or Disease | Intervention/Treatment | Phase |
|---|---|---|
|
Study Design
Study Type:
Observational
Actual Enrollment
:
150 participants
Observational Model:
Case-Only
Time Perspective:
Prospective
Official Title:
Bactericidal Effect of Silver Nanoparticles on Methecillin and Vancomycin Resistant Staphylococcus. Aureus (MRSA) Isolated From Critically Ill Patients
Actual Study Start Date
:
Jun 1, 2020
Actual Primary Completion Date
:
Oct 5, 2020
Actual Study Completion Date
:
Oct 13, 2020
Arms and Interventions
| Arm | Intervention/Treatment |
|---|---|
| Methicillin resistant staphylococcus aureus
|
Other: silver nanoparticles
effect silver nanoparticles will be examined on multidrug resistant bacteria
|
| vancomycin resistent staphylococcus aureus
|
Other: silver nanoparticles
effect silver nanoparticles will be examined on multidrug resistant bacteria
|
Outcome Measures
Primary Outcome Measures
- bactericidal effect of silver nanoparticles on multidrug resistant bacteria [24 hours]
Eligibility Criteria
Criteria
Ages Eligible for Study:
N/A
and Older
Sexes Eligible for Study:
All
Inclusion Criteria:
- Intensive care patients
Exclusion Criteria:
- none
Contacts and Locations
Locations
| Site | City | State | Country | Postal Code | |
|---|---|---|---|---|---|
| 1 | Assiut university | Assiut | Egypt | 71111 |
Sponsors and Collaborators
- Assiut University
Investigators
None specified.Study Documents (Full-Text)
None provided.More Information
Publications
None provided.Responsible Party:
Rasha Hamed,
lecturer of anaesthesia,
Assiut University
ClinicalTrials.gov Identifier:
NCT04431440
Other Study ID Numbers:
- XXXXX
First Posted:
Jun 16, 2020
Last Update Posted:
Nov 5, 2020
Last Verified:
Nov 1, 2020
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No